每經AI快訊，推動(dong)社(she)會醫(yi)(yi)(yi)療(liao)保(bao)(bao)障(zhang)水平進一步提(ti)(ti)升(sheng)(sheng)，保(bao)(bao)險(xian)(xian)業(ye)(ye)(ye)啟動(dong)商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)險(xian)(xian)藥品(pin)目(mu)錄體(ti)系建(jian)(jian)設。記者獲悉，中國(guo)保(bao)(bao)險(xian)(xian)行(xing)業(ye)(ye)(ye)協(xie)會近期組織召開(kai)座(zuo)談(tan)會，研(yan)究推進商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)保(bao)(bao)險(xian)(xian)藥品(pin)目(mu)錄體(ti)系建(jian)(jian)設。記者從與(yu)會人士處了(le)解到(dao)，該目(mu)錄體(ti)系的(de)(de)(de)建(jian)(jian)設目(mu)標是“全覆蓋、多層(ceng)次”，與(yu)基本醫(yi)(yi)(yi)保(bao)(bao)“廣覆蓋、保(bao)(bao)基本”的(de)(de)(de)定(ding)位互為補充，旨(zhi)在更(geng)好發揮商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)保(bao)(bao)險(xian)(xian)的(de)(de)(de)補充支(zhi)(zhi)付(fu)(fu)作(zuo)用，助力我國(guo)多層(ceng)次醫(yi)(yi)(yi)療(liao)保(bao)(bao)障(zhang)體(ti)系建(jian)(jian)設。業(ye)(ye)(ye)內(nei)專(zhuan)家(jia)表示，此前，商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)保(bao)(bao)險(xian)(xian)的(de)(de)(de)支(zhi)(zhi)付(fu)(fu)范圍是各家(jia)保(bao)(bao)險(xian)(xian)公(gong)司參(can)考基本醫(yi)(yi)(yi)保(bao)(bao)藥品(pin)目(mu)錄各自擬定(ding)的(de)(de)(de)，行(xing)業(ye)(ye)(ye)層(ceng)面未有相應(ying)標準(zhun)體(ti)系。商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)險(xian)(xian)藥品(pin)目(mu)錄體(ti)系建(jian)(jian)設，將推動(dong)商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)保(bao)(bao)險(xian)(xian)支(zhi)(zhi)付(fu)(fu)范疇走向規(gui)范化、標準(zhun)化、專(zhuan)業(ye)(ye)(ye)化。一方面有利于(yu)更(geng)好發揮商(shang)(shang)業(ye)(ye)(ye)健(jian)康(kang)(kang)保(bao)(bao)險(xian)(xian)的(de)(de)(de)補充支(zhi)(zhi)付(fu)(fu)作(zuo)用，提(ti)(ti)升(sheng)(sheng)消費者的(de)(de)(de)健(jian)康(kang)(kang)保(bao)(bao)障(zhang)水平；另一方面有利于(yu)提(ti)(ti)升(sheng)(sheng)保(bao)(bao)險(xian)(xian)業(ye)(ye)(ye)與(yu)藥企談(tan)判中的(de)(de)(de)話語權，或將推動(dong)藥品(pin)與(yu)醫(yi)(yi)(yi)療(liao)器械價格下降(jiang)，提(ti)(ti)升(sheng)(sheng)醫(yi)(yi)(yi)療(liao)服(fu)務普惠性。（上海證(zheng)券報）